SARS-CoV-2 in immunocompromised individuals-Reference-Cited by-同舟云学术

SARS-CoV-2 in immunocompromised individuals

Published:2022-10 Issue:10 Volume:55 Page:1779-1798
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

DeWolf Susan,Laracy Justin C.,Perales Miguel-Angel,Kamboj Mini,van den Brink Marcel R.M.,Vardhana Santosha^ORCID

Funder

Leukemia and Lymphoma Society

Lymphoma Foundation

National Institute on Aging

Pershing Square Sohn Cancer Research Alliance

National Heart, Lung, and Blood Institute

Parker Institute for Cancer Immunotherapy

Cycle for Survival

Conrad N. Hilton Foundation

National Cancer Institute

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference241 articles.

1. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies;Achiron;Ther. Adv. Neurol. Disord.,2021

2. Efficacy of the mRNA-based BNT162b2 COVID-19 vaccine in patients with solid malignancies treated with anti-neoplastic drugs;Agbarya;Cancers,2021

3. Covid-19 and kidney transplantation;Akalin;N. Engl. J. Med.,2020

4. Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative;Andersen;Lancet. Rheumatol.,2022

5. Effect of hydrocortisone on mortality and organ support in patients With severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial;Angus;JAMA,2020

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of isavuconazole on the pharmacokinetics of sunitinib and its mechanism;BMC Cancer;2024-09-11

2. Detailed tracking of antigen and antibody levels during coronavirus disease 2019 treatment in an immunosuppressed patient with anti-neutrophil cytoplasmic autoantibody-associated vasculitis;Journal of Infection and Chemotherapy;2024-09

3. CD4 ⁺ and CD8 ⁺ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment;Science Advances;2024-08-23

4. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China;The Lancet Infectious Diseases;2024-08

5. Persistent COVID-19 in immunocompromised patients—Israeli society of infectious diseases consensus statement on diagnosis and management;Clinical Microbiology and Infection;2024-08